Shares of Gelteq Limited (NASDAQ:GELS – Get Free Report) rose 5.1% on Wednesday . The company traded as high as $2.14 and last traded at $2.06. Approximately 25,626 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 69,447 shares. The stock had previously closed at $1.96.
Gelteq Trading Up 5.1 %
Gelteq Company Profile
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.
Further Reading
- Five stocks we like better than Gelteq
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What Does Downgrade Mean in Investing?
- How Do Stock Buybacks Affect Shareholders?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
